Orbimed Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
107
Total Value
4035711615
Accession Number
0001172661-25-002355
Form Type
13F-HR
Manager Name
Orbimed Advisors LLC
Data Enrichment
92% identified
98 identified9 unidentified

Holdings

107 positions
Manager:
Search and click to pin securities to the top
Page 5 of 6
Bicara Therapeutics Inc.
Shares:
298301(+0.0%)
Value:
$3.9B(-25.2%)
Q32 Bio Inc.
Shares:
2252987(+0.0%)
Value:
$3.7B(-52.0%)
BioAge Labs, Inc.
Shares:
921959(+0.0%)
Value:
$3.5B(-35.1%)
Repare Therapeutics Inc.
Shares:
3322488(+0.0%)
Value:
$3.3B(-24.7%)
Structure Therapeutics Inc.
Shares:
150000(+0.0%)
Value:
$2.6B(-36.2%)
Passage BIO, Inc.
Shares:
7034626(-5.0%)
Value:
$2.5B(-40.8%)
INSMED Inc
Shares:
28659(-69.7%)
Value:
$2.2B(-66.5%)
Ceribell, Inc.
Shares:
112500(+0.0%)
Value:
$2.2B(-25.8%)
Instil Bio, Inc.
Shares:
116785(+0.0%)
Value:
$2.0B(-9.1%)
16385C104
Shares:
1741273(+0.0%)
Value:
$1.9B(-39.8%)
Cardiff Oncology, Inc.
Shares:
573884(-62.7%)
Value:
$1.8B(-73.0%)
X4 Pharmaceuticals, Inc
Shares:
6776515(-5.0%)
Value:
$1.6B(-69.4%)
Nkarta, Inc.
Shares:
821400(+0.0%)
Value:
$1.5B(-26.1%)
Traws Pharma, Inc.
Shares:
605531(+0.0%)
Value:
$1.4B(-74.1%)
FATE THERAPEUTICS INC
Shares:
1680580(+0.0%)
Value:
$1.3B(-52.1%)
Turnstone Biologics Corp.
Shares:
3099265(+0.0%)
Value:
$1.3B(-17.5%)
Amylyx Pharmaceuticals, Inc.
Shares:
348000(+0.0%)
Value:
$1.2B(-6.3%)
BiomX Inc.
Shares:
1787767(+0.0%)
Value:
$993.5M(-23.9%)
Kezar Life Sciences, Inc.
Shares:
192700(+0.0%)
Value:
$940.4M(-27.4%)
Tango Therapeutics, Inc.
Shares:
550000(+0.0%)
Value:
$753.5M(-55.7%)